Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action

September 20, 2022
Guest: Kim Newlin, MSN, ANP, FPCNA and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA

Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renal protective properties. Join us with guests Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.

You can earn 0.5 contact hours and .05 pharmacology hours from listening to this podcast episode and completing the course components.

This podcast is supported by independent educational grants from Merck Sharpe Dohme Corporation and the Pfizer-Merck Alliance.

Episode Resources

Subscribe Today

Don't miss an episode! Listen to the Heart to Heart Nurses podcast on your favorite podcast listening service.

Other Episodes

Heart Failure Management: Lifestyle and Self-Care
September 20, 2022
Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA and Binu Koirala, PHD, MGS, RN
Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action
September 20, 2022
Kim Newlin, MSN, ANP, FPCNA and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA
Heart Failure Management: Health Equity and Access to Care
September 20, 2022
Binu Koirala, PHD, MGS, RN and Kim Newlin, MSN, ANP, FPCNA
AFib Management in Clinical Practice
September 6, 2022
Bill Miles, MD, FACC
AFib and Sleep Apnea
September 6, 2022
Lisa Maher, DNP, ARNP, FNP-BC, FPCNA